FuturHealth Launches Affirm to Offer a Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness Solutions
FuturHealth has partnered with Affirm (NASDAQ: AFRM) to offer flexible payment solutions for GLP-1 medications and wellness services. The integration allows approved customers to finance treatments like Wegovy and Ozempic, which can cost over $1,000 monthly, through transparent payment plans with 0% APR options.
Customers can select Affirm at checkout, undergo a quick eligibility check, and choose between biweekly or monthly payment schedules. The partnership aims to make personalized wellness more accessible while ensuring responsible lending practices with no late or hidden fees.
According to Affirm's VP of SMB and Platform Partnerships, the company has experienced 90% year-over-year growth in healthcare provider partnerships, reflecting increasing consumer demand for flexible healthcare payment options.
FuturHealth ha stretto una partnership con Affirm (NASDAQ: AFRM) per offrire soluzioni di pagamento flessibili per i farmaci GLP-1 e i servizi di benessere. L'integrazione consente ai clienti approvati di finanziare trattamenti come Wegovy e Ozempic, che possono costare oltre $1.000 al mese, attraverso piani di pagamento trasparenti con opzioni a 0% di APR.
I clienti possono selezionare Affirm al momento del pagamento, effettuare un rapido controllo di idoneità e scegliere tra programmi di pagamento bisettimanali o mensili. La partnership mira a rendere il benessere personalizzato più accessibile, garantendo al contempo pratiche di prestito responsabili senza spese tardive o nascoste.
Secondo il VP di Affirm per le partnership SMB e Platform, l'azienda ha registrato una crescita del 90% anno su anno nelle partnership con i fornitori di assistenza sanitaria, riflettendo la crescente domanda dei consumatori per opzioni di pagamento flessibili nel settore sanitario.
FuturHealth se ha asociado con Affirm (NASDAQ: AFRM) para ofrecer soluciones de pago flexibles para medicamentos GLP-1 y servicios de bienestar. La integración permite a los clientes aprobados financiar tratamientos como Wegovy y Ozempic, que pueden costar más de $1,000 al mes, a través de planes de pago transparentes con opciones de 0% de APR.
Los clientes pueden seleccionar Affirm al momento de pagar, realizar un rápido chequeo de elegibilidad y elegir entre programas de pago quincenales o mensuales. La asociación tiene como objetivo hacer que el bienestar personalizado sea más accesible, asegurando al mismo tiempo prácticas de préstamo responsables sin tarifas ocultas o por retraso.
Según el VP de Affirm para asociaciones SMB y de Plataforma, la empresa ha experimentado un crecimiento del 90% año tras año en asociaciones con proveedores de atención médica, lo que refleja la creciente demanda de los consumidores por opciones de pago flexibles en el sector de la salud.
FuturHealth는 Affirm (NASDAQ: AFRM)와 협력하여 GLP-1 약물 및 웰니스 서비스에 대한 유연한 결제 솔루션을 제공합니다. 이 통합을 통해 승인된 고객은 월 $1,000 이상이 될 수 있는 Wegovy 및 Ozempic와 같은 치료를 0% APR 옵션이 있는 투명한 결제 계획을 통해 금융 지원을 받을 수 있습니다.
고객은 결제 시 Affirm을 선택하고 빠른 자격 확인을 거쳐 격주 또는 월간 지불 일정 중에서 선택할 수 있습니다. 이 파트너십은 맞춤형 웰니스 접근성을 높이는 것을 목표로 하며, 연체료나 숨겨진 수수료 없이 책임 있는 대출 관행을 보장합니다.
Affirm의 SMB 및 플랫폼 파트너십 부사장에 따르면, 이 회사는 의료 제공자와의 파트너십에서 연간 90% 성장률을 기록했으며, 이는 유연한 의료 결제 옵션에 대한 소비자의 수요 증가를 반영합니다.
FuturHealth s'est associé à Affirm (NASDAQ: AFRM) pour offrir des solutions de paiement flexibles pour les médicaments GLP-1 et les services de bien-être. L'intégration permet aux clients approuvés de financer des traitements tels que Wegovy et Ozempic, qui peuvent coûter plus de 1 000 $ par mois, grâce à des plans de paiement transparents avec des options à 0 % de TAEG.
Les clients peuvent sélectionner Affirm lors du paiement, effectuer un rapide contrôle d'éligibilité et choisir entre des programmes de paiement bihebdomadaires ou mensuels. Ce partenariat vise à rendre le bien-être personnalisé plus accessible tout en garantissant des pratiques de prêt responsables sans frais de retard ou cachés.
Selon le VP d'Affirm pour les partenariats SMB et plateforme, l'entreprise a connu une croissance de 90 % d'une année sur l'autre dans ses partenariats avec les prestataires de soins de santé, reflétant la demande croissante des consommateurs pour des options de paiement flexibles dans le secteur de la santé.
FuturHealth hat eine Partnerschaft mit Affirm (NASDAQ: AFRM) geschlossen, um flexible Zahlungsoptionen für GLP-1-Medikamente und Wellness-Dienstleistungen anzubieten. Die Integration ermöglicht es genehmigten Kunden, Behandlungen wie Wegovy und Ozempic, die über 1.000 $ pro Monat kosten können, über transparente Zahlungspläne mit 0% APR-Optionen zu finanzieren.
Kunden können Affirm beim Checkout auswählen, eine schnelle Berechtigungsprüfung durchführen und zwischen zweiwöchentlichen oder monatlichen Zahlungsplänen wählen. Die Partnerschaft zielt darauf ab, personalisierte Wellness zugänglicher zu machen und gleichzeitig verantwortungsvolle Kreditpraktiken ohne verspätete oder versteckte Gebühren sicherzustellen.
Laut dem VP von Affirm für SMB- und Plattformpartnerschaften hat das Unternehmen ein Wachstum von 90 % im Jahresvergleich bei Partnerschaften mit Gesundheitsdienstleistern erfahren, was die steigende Nachfrage der Verbraucher nach flexiblen Zahlungsoptionen im Gesundheitswesen widerspiegelt.
- 90% year-over-year growth in healthcare provider partnerships
- Expansion into high-value healthcare market with $1000+ monthly transactions
- Strategic partnership with FuturHealth increases market presence in wellness sector
- Potential credit risk from high-value healthcare financing
- 0% APR offerings may impact profit margins
Insights
Affirm's partnership with FuturHealth represents a strategic expansion into healthcare financing, specifically targeting the high-cost GLP-1 medication market. With medications like Wegovy and Ozempic costing upwards of
The recurring nature of medication payments creates an attractive business opportunity compared to one-time retail purchases. Patients need these medications monthly, potentially generating consistent transaction volume and merchant fees. This expansion aligns with Affirm's growing healthcare presence, evidenced by their
For Affirm, this partnership offers several strategic advantages: diversification beyond traditional retail, entry into the rapidly growing weight management market, and potential for higher average transaction values by including comprehensive wellness solutions. The biweekly and monthly payment options with transparent terms position Affirm competitively in a sector historically plagued by confusing payment structures.
The 0% APR offerings mentioned could impact margins but likely serve as a customer acquisition tool in this new vertical. By eliminating late fees and hidden charges, Affirm addresses traditional pain points in healthcare financing while maintaining their brand promise. This approach could drive adoption and potentially establish Affirm as a preferred payment solution in the expanding GLP-1 medication market.
This partnership addresses a critical market friction point in the GLP-1 medication space. These highly effective but expensive treatments create significant financial barriers to access, with monthly costs exceeding
Healthcare financing presents different risk-reward dynamics compared to retail. Medication financing typically shows stronger repayment patterns as patients prioritize health necessities over discretionary purchases. The inclusion of broader wellness services (meal plans, consultations, lab work) enables higher transaction values while supporting better treatment outcomes.
This move positions Affirm at the intersection of several healthcare trends: the mainstreaming of GLP-1 medications, increasing consumer demand for transparent healthcare payment options, and the shift toward comprehensive weight management approaches. The
From a competitive standpoint, by offering both short-term (biweekly) and longer-term monthly payment options, Affirm creates flexibility that traditional healthcare financing often lacks. This adaptability, combined with their commitment to transparency and no hidden fees, addresses longstanding customer pain points in medical financing where confusing terms have historically damaged patient trust and deterred treatment adherence.
These medications and wellness solutions have shown effectiveness in managing weight and related health conditions but can cost upwards of
As is always true with Affirm, FuturHealth customers will only be approved for financing Affirm believes can and will be repaid, and Affirm will not charge any late or hidden fees.
"Launching with Affirm is an important step in advancing FuturHealth's mission to make personalized, science-backed wellness more accessible at scale," said FuturHealth co-founder & CEO Luke Mahoney. "Flexible, transparent payment options are essential to that goal, and Affirm's breadth of payment plans — including longer terms — and commitment to no late or hidden fees were key reasons we chose to offer them at checkout. This launch helps us deliver high-quality care with greater convenience for our customers."
"Consumers are increasingly seeking flexibility and clarity in how they pay for healthcare, and Affirm is proud to deliver that," said Yvonne Herrera, VP of SMB and Platform Partnerships at Affirm. "By offering the ability to pay in a way that fits their needs, we're giving individuals the freedom to manage costs on their own terms, without gotchas. This level of transparency and choice has historically been unavailable in healthcare, which is why we've seen
Customers can visit FuturHealth's website to select Affirm as a payment option today.
About FuturHealth:
FuturHealth is your partner in weight loss, providing personalized guidance designed to work with your everyday life. Together with a team of doctors, dieticians, and weight-loss experts, we combine scientifically-proven medications with clinically-crafted, expertly-curated meals for quick, easy, effective, and affordable wins. Founded with a mission to create a holistic and personalized alternative to traditional, one-size-fits-all weight-loss solutions, we meet each person where they are on their unique journey, empowering them to confidently take control of their well-being at every step of the way. With a network of 6,000 providers across 48 states, FuturHealth has transformed the lives of over 1.5 million patients and counting. In under a year, it has achieved an extraordinary
About Affirm:
Affirm's mission is to deliver honest financial products that improve lives. By building a new kind of payment network – one based on trust, transparency and putting people first – we empower millions of consumers to spend and save responsibly, and give thousands of businesses the tools to fuel growth. Unlike most credit cards and other pay-over-time options, we never charge any late or hidden fees. Follow Affirm on social media: LinkedIn | Instagram | Facebook | X.
Payment options through Affirm are subject to eligibility, and are provided by these lending partners: affirm.com/lenders. CA residents: Loans by Affirm Loan Services, LLC are made or arranged pursuant to California Finance Lender license 60DBO-111681.
View original content to download multimedia:https://www.prnewswire.com/news-releases/futurhealth-launches-affirm-to-offer-a-flexible-transparent-way-to-pay-over-time-for-glp-1-medications-and-wellness-solutions-302409575.html
SOURCE FuturHealth
FAQ
How much can customers save on GLP-1 medications through FuturHealth's Affirm partnership?
What payment terms does Affirm (AFRM) offer for FuturHealth's wellness services?
What is Affirm's (AFRM) growth rate in healthcare provider partnerships as of March 2025?
What services can be financed through Affirm on FuturHealth's platform?
